These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33086961)

  • 21. [A case of bucillamine-induced pneumonitis].
    Tanaka H; Nakahara K; Goto K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Apr; 30(4):695-701. PubMed ID: 1405091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis.
    Yoshida A; Morozumi K; Suganuma T; Sugito K; Ikeda M; Oikawa T; Fujinami T; Takeda A; Koyama K
    Am J Nephrol; 1991; 11(4):284-8. PubMed ID: 1799186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and review of the literature.
    Isozaki T; Kimura M; Ikegaya N; Arai T; Fujigaki Y; Hishida A; Kaneko E
    Clin Investig; 1992 Nov; 70(11):1036-42. PubMed ID: 1472834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome.
    Hase I; Kurasawa K; Takizawa H; Yamaguchi B; Sakuma H; Ishii Y
    Intern Med; 2018 Jul; 57(13):1887-1892. PubMed ID: 29434155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome.
    Hur JW; Lee CW; Yoo DH
    J Korean Med Sci; 2006 Jun; 21(3):585-7. PubMed ID: 16778412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pemphigus foliaceus induced by bucillamine.
    Fujita H; Iguchi M; Watanabe R; Asahina A
    Eur J Dermatol; 2007; 17(1):98-9. PubMed ID: 17324844
    [No Abstract]   [Full Text] [Related]  

  • 27. Bucillamine-induced pemphigus vulgaris.
    Yanagishita T; Tamada Y; Watanabe D
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1242-3. PubMed ID: 24641261
    [No Abstract]   [Full Text] [Related]  

  • 28. Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption.
    Izumi A; Katsumi S; Kobayashi N; Niizeki H; Asada H; Miyagawa S
    J Dermatol; 2005 May; 32(5):397-401. PubMed ID: 16043905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats.
    Hayashi M; Matsunaga K; Okahara A; Mita S
    J Rheumatol; 1991 May; 18(5):691-5. PubMed ID: 1865415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gigantomastia in pregnancy with an accessory axillary mass masquerading as inflammatory carcinoma.
    Lokuhetty MD; Saparamadu PA; Al-Sajee DM; Al-Ajmi R
    Diagn Cytopathol; 2011 Feb; 39(2):141-3. PubMed ID: 21254465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilic bronchitis presenting with only severe dry cough due to bucillamine.
    Ogawa H; Fujimura M; Heki U; Kitagawa M; Matsuda T
    Respir Med; 1995 Mar; 89(3):219-21. PubMed ID: 7746916
    [No Abstract]   [Full Text] [Related]  

  • 32. Bucillamine-induced hypersensitivity pneumonitis.
    Kurashima K; Nakao S; Fujimura M; Matsuda T
    Chest; 1992 May; 101(5):1479-80. PubMed ID: 1582337
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug eruption due to bucillamine.
    Kimura M; Kawada A
    Contact Dermatitis; 1998 Aug; 39(2):98-9. PubMed ID: 9746202
    [No Abstract]   [Full Text] [Related]  

  • 34. Idiopathic gigantomastia: newer mechanistic insights implicating the paracrine milieu.
    Das L; Rai A; Vaiphei K; Garg A; Mohsina S; Bhansali A; Dutta P; Tripathy S
    Endocrine; 2019 Nov; 66(2):166-177. PubMed ID: 31502211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gigantomastia--a classification and review of the literature.
    Dancey A; Khan M; Dawson J; Peart F
    J Plast Reconstr Aesthet Surg; 2008; 61(5):493-502. PubMed ID: 18054304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yellow nail induced by bucillamine.
    Ishizaki C; Sueki H; Kohsokabe S; Nishida H
    Int J Dermatol; 1995 Jul; 34(7):493-4. PubMed ID: 7591416
    [No Abstract]   [Full Text] [Related]  

  • 37. [Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis].
    Baba N; Nomura T; Sakemi T; Uchida M; Watanabe T
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):629-34. PubMed ID: 1920943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced pemphigus: A systematic review of 170 patients.
    Ghaedi F; Etesami I; Aryanian Z; Kalantari Y; Goodarzi A; Teymourpour A; Tavakolpour S; Mahmoudi H; Daneshpazhooh M
    Int Immunopharmacol; 2021 Mar; 92():107299. PubMed ID: 33418246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral axillary masses mimicking as accessory breast with multiple fibroadenoma and bilateral gigantomastia in HIV-positive patient.
    Singh S; Mishra AK; Tewari S; Kumar S
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
    Matsuno H; Kitano T; Matsushita I; Tsuji H; Ochiai H
    Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.